Obesity and diabetes mellitus in patients with sickle cell disease

Tim Jang1, George Mo1, Connor Stewart1

  • 1Division of Hematology and Oncology, SUNY Downstate Health Sciences University, 450 Clarkson Avenue MSC #20, Brooklyn, NY, 11203, USA.

Annals of Hematology
|June 20, 2021
PubMed

Insights

Sickle cell disease (SCD) patients show lower rates of obesity and diabetes mellitus compared to non-SCD peers. However, obesity in SCD patients is linked to a higher prevalence of diabetes mellitus.

Area of Science:

  • Hematology
  • Endocrinology
  • Public Health

Background:

  • Obesity and diabetes mellitus are significant health concerns, particularly in the African-American/Black population, leading to chronic conditions.
  • Their presence in sickle cell disease (SCD) patients can exacerbate multimorbidity, impacting quality of life and lifespan.
  • Understanding these comorbidities in SCD is crucial for comprehensive patient care.

Purpose of the Study:

  • To determine the prevalence of obesity and diabetes mellitus in a cohort of patients with sickle cell disease (SCD).
  • To compare these prevalence rates with those of their non-SCD peers within the same racial/ethnic group.
  • To explore associations between obesity and diabetes mellitus within the SCD population.

Main Methods:

  • A chart survey was conducted on a cohort of 449 patients diagnosed with sickle cell disease (SCD).
  • Prevalence rates of obesity and diabetes mellitus were calculated for the SCD cohort.
  • Comparisons were made with expected prevalence rates in the general population of the same race/ethnicity.

Main Results:

  • Patients with sickle cell disease (SCD) exhibited lower prevalence rates of both obesity and diabetes mellitus compared to their non-SCD peers.
  • These lower prevalence rates were consistent across different genders and observed in individuals over six years of age.
  • Within the SCD cohort, obesity was significantly associated with a higher prevalence of diabetes mellitus.

Conclusions:

  • Sickle cell disease (SCD) may confer a protective effect against the development of obesity and diabetes mellitus.
  • The observed lower prevalence warrants further investigation into potential underlying mechanisms, such as altered metabolism or gut microbiome.
  • Despite lower overall prevalence, the association between obesity and diabetes mellitus in SCD patients highlights the need for continued monitoring and management of these conditions.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.6K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.4K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.1K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.2K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.8K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
843